Published in Virology on November 01, 1991
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol (1995) 2.70
A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J Virol (1997) 1.65
Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis (2002) 1.51
First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol (1994) 1.17
Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology (2007) 1.16
Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated downregulation of Sindbis virus replication in persistently infected neurons. J Virol (1995) 1.10
The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity. PLoS Negl Trop Dis (2010) 0.99
Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus. J Virol (1993) 0.88
Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection. J Virol (2010) 0.86
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol (2000) 13.34
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet (2001) 6.49
Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood (1966) 6.49
A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol Med (1969) 4.70
Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 4.61
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol (2001) 4.27
Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology (1998) 3.80
The defibrination syndrome: clinical features and laboratory diagnosis. Br J Haematol (1967) 3.67
Comparison of the tine and Mantoux tuberculin tests. Report of the Tuberculin Subcommittee of the Researched Committee of the British Thoracic Association. Br Med J (1978) 3.62
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology (1997) 3.48
West Nile virus: a reemerging global pathogen. Emerg Infect Dis (2001) 3.27
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Circumstances of death from asthma. Br Med J (Clin Res Ed) (1984) 2.71
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69
Experimentally induced infection of dogs, cats, and nonhuman primates with Ehrlichia equi, etiologic agent of equine ehrlichiosis. Am J Vet Res (1975) 2.67
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis (1999) 1.93
Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology (1990) 1.91
3-D FLASH imaging using a single surface coil and a new adiabatic pulse, BIR-4. Invest Radiol (1990) 1.88
West Nile virus in the United States: guidelines for detection, prevention, and control. Viral Immunol (2000) 1.85
Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology (1982) 1.80
GAA instability in Friedreich's Ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases. Mol Cell (1998) 1.68
Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses. Am J Trop Med Hyg (1990) 1.66
Methods for the production of clinically effective intermediate- and high-purity factor-VIII concentrates. Br J Haematol (1971) 1.64
The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology (1985) 1.62
Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J Immunol (1982) 1.60
Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968. Thromb Diath Haemorrh (1969) 1.59
Studies on the Photosynthetic Reaction. III. The Effects of Various Inhibitors upon Growth and Carbonate-Fixation in Chlorella Pyrenoidosa. Plant Physiol (1957) 1.59
Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol (1984) 1.58
Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology (1993) 1.56
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg (1997) 1.45
The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis (2000) 1.43
Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology (1989) 1.42
The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology (1994) 1.33
Monoclonal antibodies against the flavivirus West Nile. J Gen Virol (1982) 1.33
Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response. Arch Virol (1990) 1.31
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region. Am J Trop Med Hyg (1998) 1.30
Color vision deficits during laser lithotripsy using safety goggles for coumarin green or alexandrite but not with holmium:YAG laser safety goggles. J Urol (1998) 1.30
Detection of St. Louis encephalitis virus antigen in mosquitoes by capture enzyme immunoassay. J Clin Microbiol (1987) 1.29
Equine piroplasmosis: production of antigens for the complement-fixation test. Am J Vet Res (1969) 1.28
Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus. Virology (1980) 1.28
Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br J Haematol (1982) 1.28
Effect of intravenous injection of salbutamol in asthma. Br J Clin Pharmacol (1975) 1.26
Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Virology (1990) 1.25
Experimentally induced sarcocystis infection in calves: pathology. Am J Vet Res (1975) 1.25
Equine piroplasmosis: complement-fixation titers of horses infected with Babesia caballi. Am J Vet Res (1969) 1.25
Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features. Leukemia (2012) 1.24
Development of an enzyme-linked immunosorbent assay for the identification of arthropod-borne togavirus antibodies. J Gen Virol (1982) 1.24
Experimental infections with African Trypanosomes. VI. Glomerulonephritis involving the alternate pathway of complement activation. Am J Trop Med Hyg (1974) 1.23
Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature. Arch Virol (2002) 1.22
Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of subtype 1 Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay. J Clin Microbiol (1997) 1.20
Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis (1994) 1.18
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. J Virol (1985) 1.18
Identification of Highlands J virus from a Florida horse. Am J Trop Med Hyg (1988) 1.16
Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res (1987) 1.16
Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. Virology (1985) 1.12
Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol (1995) 1.11
Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J Virol (1988) 1.10
A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes. J Gen Virol (1991) 1.10
Properties of monoclonal antibodies directed against the glycoproteins of Sindbis virus. J Gen Virol (1982) 1.09
Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine (1988) 1.09
Stability of St. Louis encephalitis viral antigen detected by enzyme immunoassay in infected mosquitoes. J Clin Microbiol (1988) 1.08
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol. Leukemia (2011) 1.07
The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells. Leukemia (2012) 1.05
Comparison of multiple puncture liquid tuberculin test with Mantoux test. Lancet (1981) 1.05
Metabolic response to intravenous salbutamol therapy in acute asthma. Thorax (1977) 1.04
An effective program for reducing group A streptococcal prevalence. Pediatrics (1971) 1.04
Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus. Am J Trop Med Hyg (1988) 1.04
Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres. Infect Immun (1995) 1.03
Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology (1995) 1.02
Emergence of epidemic O'nyong-nyong fever in southwestern Uganda, after an absence of 35 years. Emerg Infect Dis (1997) 1.02
Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. J Gen Virol (1988) 1.01
Hematologic, biochemical, and parasitologic parameters of the night monkey (Aortus trivirgatus). Lab Anim Sci (1971) 1.01
Intravenous infusion of salbutamol in the treatment of asthma. Br J Clin Pharmacol (1975) 1.00
Genetic variation of Venezuelan equine encephalitis virus strains of the ID variety in Colombia. Am J Trop Med Hyg (1988) 1.00
Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J Gen Virol (1993) 1.00
Preparation of the major plasma fractions by solid-phase polyelectrolytes. J Lab Clin Med (1978) 1.00
Experimental infections with African trypanosomes. V. Preliminary parasitological, clinical, hematological, serological, and pathological observations in rhesus monkeys infected with Trypanosoma rhodesiense. Am J Trop Med Hyg (1973) 0.98
Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol (1992) 0.98
Experimental infection with Schistosoma japonicum in chimpanzees. Am J Trop Med Hyg (1971) 0.98
Phosphoinositide 3-kinase facilitates antigen-stimulated Ca(2+) influx in RBL-2H3 mast cells via a phosphatidylinositol 3,4,5-trisphosphate-sensitive Ca(2+) entry mechanism. J Biol Chem (2001) 0.97
Development of Sarcocystis fusiformis in calves infected with sporocysts from dogs. J Parasitol (1973) 0.97
Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide. Virology (1990) 0.97
Monomeric class I molecules mediate TCR/CD3 epsilon/CD8 interaction on the surface of T cells. J Immunol (2001) 0.97
Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage (2010) 0.97